Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications

Patients experiencing financial distress as a side-effect of cancer are not only reported in the United States, but also in third-party payer healthcare systems in Europe. Since validated survey instruments are a prerequisite for robust and comparable results, we aimed to compile and classify availa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Witte, Julian (VerfasserIn) , Mehlis, Katja (VerfasserIn) , Winkler, Eva C. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 02 May 2019
In: Annals of oncology
Year: 2019, Jahrgang: 30, Heft: 7, Pages: 1061-1070
ISSN:1569-8041
DOI:10.1093/annonc/mdz140
Online-Zugang:Verlag, Volltext: https://doi.org/10.1093/annonc/mdz140
Verlag: https://academic.oup.com/annonc/article/30/7/1061/5482566
Volltext
Verfasserangaben:J. Witte, K. Mehlis, B. Surmann, R. Lingnau, O. Damm, W. Greiner & E.C. Winkler

MARC

LEADER 00000caa a2200000 c 4500
001 1679235095
003 DE-627
005 20220817004145.0
007 cr uuu---uuuuu
008 191021s2019 xx |||||o 00| ||eng c
024 7 |a 10.1093/annonc/mdz140  |2 doi 
035 |a (DE-627)1679235095 
035 |a (DE-599)KXP1679235095 
035 |a (OCoLC)1341248341 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Witte, Julian  |d 1986-  |e VerfasserIn  |0 (DE-588)143816446  |0 (DE-627)704610663  |0 (DE-576)339049952  |4 aut 
245 1 0 |a Methods for measuring financial toxicity after cancer diagnosis and treatment  |b a systematic review and its implications  |c J. Witte, K. Mehlis, B. Surmann, R. Lingnau, O. Damm, W. Greiner & E.C. Winkler 
264 1 |c 02 May 2019 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 21.10.2019 
520 |a Patients experiencing financial distress as a side-effect of cancer are not only reported in the United States, but also in third-party payer healthcare systems in Europe. Since validated survey instruments are a prerequisite for robust and comparable results, we aimed to compile and classify available instruments to enable both a better understanding of the underlying construct of financial toxicity and to facilitate further studies that are adjustable to various healthcare systems. We did a systematic literature search on studies that provide data on perceived cancer-related financial distress experienced by adult patients using PubMed, CINAHL and Web of Science databases up to 2018. We analyzed all detected instruments, items domains and questions with regard to their wording, scales and the domains of financial distress covered. Among 3298 records screened, 41 publications based on 40 studies matched our inclusion criteria. Based on the analysis of 352 different questions we identified 6 relevant subdomains that represent perceptions of and reactions to experienced financial distress: (i) active financial spending, (ii) use of passive financial resources, (iii) psychosocial responses, (iv) support seeking, (v) coping with care or (vi) coping with ones’ lifestyle. We found an inconsistent coverage and use of these domains that makes it difficult to compare and quantify the prevalence of financial distress. Moreover, some existing instruments do not reflect relevant domains for patients in third-party payer systems. There is neither a consistent understanding of the construct of financial burden nor do available instruments cover all relevant aspects of a patients’ distress perception. We encourage using the identified six domains to further develop survey instruments and adjust them to different health systems. 
700 1 |a Mehlis, Katja  |e VerfasserIn  |0 (DE-588)1084144514  |0 (DE-627)848338154  |0 (DE-576)456212205  |4 aut 
700 1 |a Winkler, Eva C.  |d 1971-  |e VerfasserIn  |0 (DE-588)1055853065  |0 (DE-627)792734823  |0 (DE-576)411905384  |4 aut 
773 0 8 |i Enthalten in  |t Annals of oncology  |d Amsterdam [u.a.] : Elsevier, 1990  |g 30(2019), 7, Seite 1061-1070  |h Online-Ressource  |w (DE-627)320428796  |w (DE-600)2003498-2  |w (DE-576)098134345  |x 1569-8041  |7 nnas  |a Methods for measuring financial toxicity after cancer diagnosis and treatment a systematic review and its implications 
773 1 8 |g volume:30  |g year:2019  |g number:7  |g pages:1061-1070  |g extent:10  |a Methods for measuring financial toxicity after cancer diagnosis and treatment a systematic review and its implications 
856 4 0 |u https://doi.org/10.1093/annonc/mdz140  |x Verlag  |x Resolving-System  |3 Volltext  |7 1 
856 4 0 |u https://academic.oup.com/annonc/article/30/7/1061/5482566  |x Verlag  |7 1 
951 |a AR 
992 |a 20191021 
993 |a Article 
994 |a 2019 
998 |g 1055853065  |a Winkler, Eva C.  |m 1055853065:Winkler, Eva C.  |d 910000  |d 912900  |d 50000  |e 910000PW1055853065  |e 912900PW1055853065  |e 50000PW1055853065  |k 0/910000/  |k 1/910000/912900/  |k 0/50000/  |p 7  |y j 
998 |g 1084144514  |a Mehlis, Katja  |m 1084144514:Mehlis, Katja  |d 910000  |d 910100  |e 910000PM1084144514  |e 910100PM1084144514  |k 0/910000/  |k 1/910000/910100/  |p 2 
999 |a KXP-PPN1679235095  |e 3525736797 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Methods for measuring financial toxicity after cancer diagnosis and treatment","title":"Methods for measuring financial toxicity after cancer diagnosis and treatment","subtitle":"a systematic review and its implications"}],"language":["eng"],"id":{"doi":["10.1093/annonc/mdz140"],"eki":["1679235095"]},"physDesc":[{"extent":"10 S."}],"relHost":[{"pubHistory":["1.1990 -"],"title":[{"subtitle":"official journal of the European Society for Medical Oncology","title":"Annals of oncology","title_sort":"Annals of oncology"}],"language":["eng"],"part":{"volume":"30","year":"2019","text":"30(2019), 7, Seite 1061-1070","pages":"1061-1070","extent":"10","issue":"7"},"disp":"Methods for measuring financial toxicity after cancer diagnosis and treatment a systematic review and its implicationsAnnals of oncology","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["320428796"],"issn":["1569-8041"],"zdb":["2003498-2"]},"note":["Gesehen am 12.11.20","Ungezählte Beil.: Supplement"],"corporate":[{"display":"European Society for Medical Oncology","role":"isb"}],"origin":[{"publisherPlace":"Amsterdam [u.a.] ; Dordrecht [u.a.] ; Oxford","dateIssuedDisp":"1990-","publisher":"Elsevier ; Kluwer ; Oxford Univ. Press","dateIssuedKey":"1990"}],"recId":"320428796","type":{"media":"Online-Ressource","bibl":"periodical"}}],"note":["Gesehen am 21.10.2019"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1679235095","origin":[{"dateIssuedDisp":"02 May 2019","dateIssuedKey":"2019"}],"person":[{"display":"Witte, Julian","role":"aut","given":"Julian","family":"Witte"},{"given":"Katja","role":"aut","display":"Mehlis, Katja","family":"Mehlis"},{"family":"Winkler","display":"Winkler, Eva C.","role":"aut","given":"Eva C."}],"name":{"displayForm":["J. Witte, K. Mehlis, B. Surmann, R. Lingnau, O. Damm, W. Greiner & E.C. Winkler"]}} 
SRT |a WITTEJULIAMETHODSFOR0220